There are a total of 57 senior academicians of the Department of Medicine and Health of the Chinese Academy of Engineering, which will be introduced in 7 periods, and today is the first issue, introducing 8 academicians (in the order of surname pinyin).
Ba Denian, Manchu, born in Siping, Jilin Province in October 1938, native of Liaoning, member of the Communist Party of China, expert in immunology, academician of the Chinese Academy of Engineering, foreign academician of the National Academy of Medicine, member of the Chinese Academy of Medical Sciences, honorary dean of Zhejiang University School of Medicine.
From September 1957 to June 1962, he studied at the Department of Medicine of Harbin Medical University. From September 1965 to June 1968, he studied at Beijing Medical University and obtained a master's degree in biochemistry after graduation. From September 1978 to June 1982, he studied at Hokkaido University in Japan and obtained a doctorate degree in medicine after graduation. From 1982 to 1990, he served as a professor and vice president of Harbin Medical University. From 1990 to 1992, he served as Education Counselor of the Chinese Embassy in Japan. From 1992 to 2002, he successively served as President of the Chinese Academy of Medical Sciences and President of Peking Union Medical College. In 1994, he was elected as an academician of the Chinese Academy of Engineering. In 1999, he was elected as a Foreign Member of the National Academy of Medicine. From 2003 to 2009, he served as the Dean of the School of Medicine, Zhejiang University. In 2009, he was appointed as the Honorary Dean of Zhejiang University School of Medicine. In 2019, he was elected as a member of the Faculty of the Chinese Academy of Medical Sciences.
Bardenian is mainly engaged in the research of molecular mechanisms of tumor immunity.
Chen Hongduo, male, Han nationality, born on February 18, 1933 in Shaoxing, Zhejiang, is a member of the Communist Party of China and the China Zhi Gong Party, an academician of the Chinese Academy of Engineering, an expert in venereal diseases, a professor of China Medical University, the director of the Key Laboratory of Immunology of the Ministry of Health, and the director of the Key Laboratory of Immunology of the Ministry of Education.
From 1950 to 1956, Chen Hongduo graduated from China Medical University; From 1956 to 1983, he served as the director of the research department of China Medical University. In 1982, he became a professor at China Medical University. From 1983 to 1985, he served as the director of the First Affiliated Hospital of China Medical University. From 1988 to 1994, he served as the dean, dean and professor of the Department of Clinical Medicine of the First Affiliated Hospital of China Medical University. In 1999, he served as the director of the Key Laboratory of Immunology, the director of the Academic Committee and the professor of the Ministry of Health, and was elected as an academician of the Chinese Academy of Engineering.
Chen Hongduo's research interests are venereology and clinical immunology.
Chen Junshi, male, born in Shanghai on June 15, 1935, originally from Hangzhou, Zhejiang, is a nutrition and food safety expert, an academician of the Chinese Academy of Engineering, a researcher and general consultant of science and technology of the National Center for Food Safety Risk Assessment, and an honorary chairman of the Chinese Society of Toxicology.
In 1956, after graduating from Beijing Medical College, Chen Junshi entered the Department of Nutrition of ** Health Research Institute; In 1964, he entered the Institute of Materia Medica, Chinese Academy of Medical Sciences, and studied for a master's degree in pharmacology. Master's degree in pharmacology in 1968; In 1980, he went to the United States as a visiting scholar and studied in the Department of Toxicology of Albany Medical College and the Department of Nutritional Sciences of Cornell University. After returning to China in 1981, he worked at the Institute of Nutrition and Food Hygiene of the Chinese Academy of Preventive Medicine. Schwarz International Award in 1984; In 2002, he joined the Institute of Nutrition and Food Safety of the Chinese Center for Disease Control and Prevention. In 2003, he was awarded an honorary doctorate in life sciences from London Metropolitan University. In 2005, he was elected as an academician of the Chinese Academy of Engineering. In 2007, he served as the chairman of the Codex Committee on Food Additives on behalf of China**; In 2009, he served as the chairman of the first National Expert Committee on Food Safety Risk Assessment; In 2010, he served as the deputy director of the National Food Safety Standards Review Committee and the chief technical engineer; In 2011, he served as a researcher and general consultant of science and technology of the National Center for Food Safety Risk Assessment; In 2014, he served as the deputy director of the Expert Committee of the National Food Safety Committee; In 2016, he won the Lifetime Achievement Award of the China Standard Innovation Contribution Award.
He is the executive editor-in-chief of Biomedical and Environmental Sciences, the editor-in-chief of Health Research, the editor-in-chief of the Chinese Journal of Preventive Medicine, and the editorial board of Nutrition and Cancer and International Journal of Cancer.
Chen's research interests include: food safety risk assessment and risk communication; food toxicology; epidemiological studies of diet, nutrition and chronic noncommunicable diseases; food fortification; Total Diet Study.
Chen Yazhu, female, born on July 23, 1936, from Ningbo, Zhejiang, is a member of the Chinese Academy of Engineering, a high-voltage technology expert, an expert in biomedical engineering, an academician of the Chinese Academy of Engineering, a professor and doctoral supervisor of Shanghai Jiao Tong University, and an honorary dean of the School of Biomedical Engineering of Shanghai Jiao Tong University.
In 1962, Chen Yazhu graduated from Shanghai Jiao Tong University with a major in high-voltage technology, and after graduating with a bachelor's degree, she engaged in higher education and scientific research at Shanghai Jiao Tong University. In 1996, he was elected as an academician of the Chinese Academy of Engineering.
Chen Yazhu mainly researches new high-voltage technology and insulation detection, physical factor tumor technology (radio frequency, ultrasound, electromagnetic wave and other physical factors), tumor comprehensive mechanism research (hyperthermia combined with radiotherapy, chemical gene**), optical detection technology, biomedical intelligent instruments, etc.
Cheng Shujun, born on December 2, 1939 in Yushan County, Jiangxi Province, is an expert in genetic toxicology, an academician of the Chinese Academy of Engineering, and a researcher at the Cancer Hospital of the Chinese Academy of Medical Sciences.
Cheng Shujun graduated from the Medical Department of Beijing Medical College in 1962. In 1965, he received a master's degree from Peking Union Medical College. From 1978 to 1981, he studied genetic toxicology at the French National Institute of Oncology. From 1986 to 1987, he was a visiting scholar at Ohio Medical College. In 1992 and 1996, he was a visiting professor at the Netherlands Cancer Institute and MD MD Anderson Cancer Center in the United States. From 1992 to 2001, he served as the Deputy Director of the Cancer Institute of the Chinese Academy of Medical Sciences and the Vice President of the Cancer Hospital. In 1999, he was elected as an academician of the Chinese Academy of Engineering. From 2003 to 2012, he served as the chairman of the Chinese Society of Environmental Mutagons; In 2019, he was appointed as a member of the Faculty of the Chinese Academy of Medical Sciences.
Shujun Cheng is mainly engaged in the study of chemotherapy** and carcinogenesis mechanism of tumors, toxicology and genetics, as well as the molecular mechanism of human lung carcinogenesis and tumor molecular marker profiling.
Cheng Tianmin, born on December 27, 1927, is a native of Yixing City, Jiangsu Province. He is a professor at the Institute of Compound Injuries of the Department of Military Preventive Medicine of the Third Military Medical University, an academician of the Chinese Academy of Engineering, and a physician of anti-origin medicine and pathology.
He graduated from the Sixth Military Medical University in 1951. In 1958, he began to study radiation sickness, and in 1960, Cheng Tianmin began to study radiation composite injury. In November 1986, he was appointed President of the Third Military Medical University. In February 1996, he was elected as an academician of the Chinese Academy of Engineering. Cheng Tianmin has also served as a member of the discipline evaluation group of the Academic Degree Committee, the chairman of the Chinese Trauma Society, a member of the expert group of the General Logistics and Health Department, and the vice chairman of the Chongqing Association for Science and Technology.
Cheng Tianmin has participated in China's nuclear tests 14 times, discovered and named the "bone marrow megakaryocyte phagocytosis phenomenon", and his research results are at the international and domestic leading level. He founded the only compound injury research institute in China and is known as a pioneer in China's original prevention medicine, especially compound injury research.
Dai Yurong, male, Han nationality, born on June 13, 1934 in Xiamen, Fujian, a native of Zhangzhou, Fujian, an expert in orthopedics and orthopedic biomechanics, an academician of the Chinese Academy of Engineering, a foreign corresponding academician of the French National Academy of Medicine, a member of the Chinese Academy of Medical Sciences, the chief scientist of the Shanghai Clinical Medical Center for Trauma Orthopedics and Bone and Joint Diseases, the director of the Institute of Bone and Joint Research of Shanghai Jiao Tong University School of Medicine, and the director of the Medical 3D Printing Innovation Research Center of Shanghai Jiao Tong University. Director of the Engineering Research Center for Clinical Transformation of Digital Medicine of the Ministry of Education, Director of the Stem Cell and Regenerative Medicine Transformation Base of the Institute of Translational Medicine, Shanghai Jiao Tong University.
In 1955, Dai graduated from Shanghai First Medical College; From 1956 to 1960, he worked in China Railway Fourth Bureau Group and Hankou Railway Central Hospital; From 1961 to 1974, he worked at Shanghai Railway Medical College. In 1974, he served as the president and professor of the Ninth People's Hospital affiliated to Shanghai Jiao Tong University School of Medicine. From 1983 to 1984, he was a visiting researcher at the Mayo Clinic and Graduate School in the United States. In 1988, he became a member of the Chinese Peasants' and Workers' Democratic Party; In 2003, he was elected as an academician of the Chinese Academy of Engineering. In 2014, he was elected as a Foreign Corresponding Member of the French National Academy of Medicine. In 2019, he was appointed as a member of the Faculty of the Chinese Academy of Medical Sciences.
Dai has long been committed to clinical and basic research in orthopedics, with special emphasis on the intersection of medicine, engineering science and biological science.
Gao Runlin, born on May 4, 1941 in Tangshan, Hebei Province, is an expert in cardiovascular diseases, an academician of the Chinese Academy of Engineering, a member of the Chinese Academy of Medical Sciences, and the chief expert, researcher and doctoral supervisor of the Department of Cardiology of Fuwai Hospital of the Chinese Academy of Medical Sciences.
Gao Runlin graduated from the Department of Medicine of Beijing Medical University in 1965 and then worked in Baoji Central Hospital in Shaanxi Province. In 1978, he was admitted to Peking Union Medical College as a graduate student. In 1981, he received a master's degree and then worked in the Department of Cardiology of Fuwai Cardiovascular Hospital. From 1985 to 1986, he studied cardiovascular interventional at Loma Linda University School of Medicine**; From 1987 to 1991, he worked in the Coronary Heart Disease Research Laboratory of Fuwai Cardiovascular Hospital; From 1992 to 1996, he served as the vice president and director of the Department of Internal Medicine of Fuwai Cardiovascular Hospital; From 1996 to 2002, he served as the fifth director of Fuwai Cardiovascular Hospital; In 1999, he was elected as an academician of the Chinese Academy of Engineering. In 2019, he was appointed as a member of the Faculty of the Chinese Academy of Medical Sciences.
Gao Runlin has been engaged in clinical and scientific research of cardiovascular diseases for a long time.
To be continued) List of high-quality authors